Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
about
Anti-endotoxin vaccines: back to the futureUlinastatin and thymosin as immune modulators for the treatment of sepsisIntravenous immunoglobulin for treating sepsis, severe sepsis and septic shockUlinastatin and thymosin as immune modulators for the treatment of sepsisImmune modulation in the treatment of respiratory infectionElevated calcitonin precursor levels are related to mortality in an animal model of sepsisPro/con clinical debate: are steroids useful in the management of patients with septic shock?Endotoxemia in critically ill patients: why a reliable test could be beneficial.Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescenceRecent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.The coagulopathy of acute sepsisAdvances in the management of sepsis and the understanding of key immunologic defectsNovel formulations for antimicrobial peptidesTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectA Dormant Microbial Component in the Development of PreeclampsiaReducing mortality in sepsis: new directionsThe ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dogTranscription factor NF kappa B expression and postsurgical organ dysfunctionBinding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypesSimilarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in miceEffect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitisSepsis: in search of cure.Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.Effect of interpretive bias on research evidenceIntensive care.Bacterial lipopolysaccharide induces expression of the stress response genes hop and H411.Intravenous immunoglobulin for treating sepsis and septic shock.IL-6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopyProbing lipase/esterase libraries for lipid A hydrolases--discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Indications, technical considerations, and strategies for renal replacement therapy in the intensive care unit.Protection against lipopolysaccharide-induced death by fluoroquinolones.Monoclonal antibodies to endotoxin in the management of sepsis.Therapies directed against endotoxin--has the time come?A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharidesCirculatory failure in septic shock. Nitric oxide: too much of a good thing?Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.
P2860
Q22305428-09CAE8AF-1D18-49E8-AE44-2C6E83DEA9D4Q24193380-B3E3B5E9-5469-49B0-9D90-4D234E09778DQ24198059-F5B8EAB0-E27A-462E-911A-3BB059C2FE12Q24202365-41E3B411-4698-4434-9816-95FCFFCC8A9FQ24791001-09BE68B3-2FAA-4001-B6D0-82E200B2A03AQ24793821-CD5CFB79-9BCF-450B-AF2A-9C84BD4873F8Q24796470-8D1CFCED-2177-4D92-A227-F1AEEF9BA08AQ24796837-5CD28AB5-027C-492D-9A8F-5DEE77BDCC16Q24801390-514AB650-0495-4398-898F-0C6C903F1CF9Q25255548-413587A3-6202-4923-B8F3-B3330282CD21Q26826950-FFDCD968-6E54-4378-9E32-9C7E9007CB67Q26865386-33D20E8A-B184-440D-924C-4F65060FFAD7Q26991771-1BC476B8-2BEF-4364-977D-79AA578FEAEBQ26996658-BE782E4F-90DD-4E18-92CC-6399E29E7CB1Q28069689-2C893528-EC77-4A73-83B9-C1CF9BC1EB22Q28195791-2CE5F88E-E661-4FD0-8D3C-C6D8AAF69F41Q28320180-00900488-B5B9-47B7-A5FF-718246E8A419Q28345627-7CFBB138-68D9-48E6-B1C7-F7ACC63D38EDQ28369550-1E713E7B-3E6A-41AA-B604-B9394EBEA1B5Q28379429-134FA06C-9857-435C-AA98-3C44C3397434Q28574454-D9B900AA-0BD9-49E0-86A1-7A345C0094AEQ30251753-798FE474-26F3-4F34-B934-A38E7EB7578DQ30452831-05B17902-E33C-45DC-B211-CE6E9EF3BF08Q30453726-54A0A888-F484-42D3-ABE0-E4E18E48EC34Q30475889-AF453402-68CE-48C0-8AD5-96BBF123C230Q30493400-B6CED5A3-4C3F-4EE5-B74F-8C5DB05D2754Q30736524-5723DA93-4238-4593-B142-08BC6907901AQ30820719-AB0390E0-6F63-4563-9E08-B3C7A5E661BFQ30881468-6EE370A8-3E32-4A81-9EA6-9710DB3EC067Q33197502-7809BEA7-871F-481E-BBB9-49BB28A3451DQ33404640-4CB31073-6EC7-4F83-94F9-995019CF4426Q33561712-5BC9D133-FDD7-4636-9F38-8D19C50214F4Q33594884-4D66F047-C897-4D93-ABFE-C009F5779293Q33606835-34552F21-28F4-42F2-AC81-953B947C83F7Q33606855-4A582490-BB40-4135-8F71-4D3249AFC955Q33608312-3F84A25D-365B-4D5D-9151-B1B592A85A9CQ33613243-D7A187E8-1236-42C4-B2D8-6DC3F41D939AQ33631108-98A6864F-EF5A-4626-93E3-74CF7053A4EBQ33751106-51C341F5-5F32-4787-82AB-0F7C9A3E090EQ33754022-67C87A26-EA79-4386-91FA-960E33EAA029
P2860
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@en
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@nl
type
label
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@en
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@nl
prefLabel
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@en
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@nl
P2093
P921
P1476
Treatment of gram-negative bac ...... The HA-1A Sepsis Study Group.
@en
P2093
Dellinger RP
Fisher CJ Jr
Straube RC
Ziegler EJ
P304
P356
10.1056/NEJM199102143240701
P407
P577
1991-02-01T00:00:00Z